Dalhousie University-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2018

  1. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

    EMBO Molecular Medicine, Vol. 10, Núm. 12